Lifang Cao

Lifang Cao

Auto-generated profile, based on publicly available information

Lifang Cao


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
YWYewen Wang
Yewen Wang
LCLifang Cao
Lifang Cao
LRLeshan Ruan
Leshan Ruan
CXChen Xingyu
Chen Xingyu
CSChunhui Song
Chunhui Song
YXYunchang Xie
Yunchang Xie
Largemouth bass ranavirus (LMBV) causes high mortality rate in largemouth bass during outbreaks, resulting in huge economic losses. Eugenol (EUG) has potent antiviral activity, showing promising potential against LMBV. Thus, to investigate EUG’s efficacy against LMBV, corresponding analysis was conducted in vivo and in vitro. Firstly, EUG demonstrated to be able to down-regulate both the mRNA and protein levels of the major capsid protein (MCP) in LMBV-infected cells. In addition, EUG could inhibit the expression of cleaved-caspase-3 in LMBV-infected fathead minnow (FHM) cell. On the other hand, EUG would not only directly regulate the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway but also affect the AMP-activated protein kinase (AMPK) pathway in FHM cells during LMBV infection. These results indicated that EUG exerts its antiviral effects by modulating both LMBV-induced apoptosis and autophagy. Notably, EUG reduced the viral load present within the tissues of LMBV-infected largemouth bass, thereby ultimately enhancing their survival rate in the culture environment by about 20%. These mechanistic assays revealed the anti-LMBV properties of EUG, which could significantly enrich the research content of plant extracts in the field of aquatic antiviral, and provide important theoretical basis for the development and application of related products.

13 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
YWYewen Wang
Yewen Wang
LCLifang Cao
Lifang Cao
LRLeshan Ruan
Leshan Ruan
CXChen Xingyu
Chen Xingyu
CSChunhui Song
Chunhui Song
YXYunchang Xie
Yunchang Xie
Largemouth bass ranavirus (LMBV) is a severely harmful pathogen in the largemouth bass culture industry. This virus causes high mortality rate in largemouth bass during its epidemic season, resulting in huge economic losses. While, eugenol (EUG) has potent antiviral activity showing promising potential to against LMBV. Thus, to investigated EUG’s efficacy against LMBV, an analysis of the autophagy and apoptosis was conducted and confirmed the anti-LMBV activity of EUG in vivo and in vitro. Firstly, EUG can not only directly inhibit the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway, but also promote the AMP-activated protein kinase (AMPK) pathway in fathead minnow (FHM) cells during LMBV infection. This effect has the capacity to activate and enhance the autophagy of the FHM cells against its apoptosis that has been induced by LMBV. Notably, EUG reduced the viral load present within the tissues of LMBV-infected largemouth bass, thereby ultimately enhancing their survival rate within a culture setting. These mechanistic assays revealed the anti-LMBV properties of EUG, which could significantly enrich the content of antiviral research and provide valuable references for aquaculture.

7 August 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
RHRuixian Huo
Ruixian Huo
HGHannan Gong
Hannan Gong
LCLifang Cao
Lifang Cao
DTDekun Tang
Dekun Tang
YCYifang Chen
Yifang Chen
SWShi-Na Wei
Shi-Na Wei
The largemouth bass (Micropterus salmoides) is an important freshwater aquaculture species in China, but the increasing incidence of disease under intensive production conditions has become a major constraint on its sustainable development. This study evaluated the effects of dietary Eucommia ulmoides extract (ELE) supplementation on growth performance, immune and antioxidant responses, intestinal health, gut microbiota, and resistance to largemouth bass virus (LMBV) in juvenile largemouth bass. During a 56-day feeding trial, fish with an initial body weight of 13.14 ± 0.11 g were fed diets containing 0, 30, 60, 90, 120, or 150 mg ELE/kg, with three replicate nets per treatment. Dietary supplementation with 60–90 mg/kg ELE significantly increased weight gain rate (p < 0.05). ELE also improved selected serum antioxidant and immune indices, with the most pronounced responses generally observed at intermediate supplementation levels. In the intestine, the increased Nrf2 and decreased Keap1 mRNA expression were consistent with the potential involvement of Keap1/Nrf2-related redox regulation. ELE also modulated the expression of inflammation- and apoptosis-related genes and increased the expression of selected tight-junction-related genes, suggesting a potential contribution to intestinal inflammatory regulation and barrier maintenance. In addition, ELE supplementation was associated with shifts in bacterial diversity and community composition, although the responses varied among supplementation levels. Following LMBV challenge, the 90 mg/kg group showed the highest observed protection, accompanied by lower splenic expression of the largemouth bass virus major capsid protein (LMBV-MCP) and proinflammatory gene expression, suggesting reduced viral activity and host inflammatory responses. Overall, dietary supplementation with 60–90 mg/kg ELE elicited the most favorable combined responses and may contribute to the regulation of growth, antioxidant and immune status, and intestinal homeostasis in largemouth bass.